Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · IEX Real-Time Price · USD

0.810

-0.036 (-4.24%)

At close: May 3, 2024, 4:00 PM

0.830

+0.020 (2.46%)

After-hours: May 3, 2024, 7:38 PM EDT

Aligos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	63	50	41	506	1,054	-	-
Market Cap Growth	-	21.95%	-91.93%	-52.00%	-	-	-
Enterprise Value	-61	-75	-73	329	823	-104	-78
PE Ratio	-0.57	-0.57	-0.42	-3.94	-9.71	-	-
PS Ratio	4.07	3.20	2.93	116.05	-	-	-
PB Ratio	0.69	0.54	0.39	2.74	4.79	-	-
P/FCF Ratio	-0.63	-0.63	-0.51	-4.34	-13.81	-	-
P/OCF Ratio	-0.63	-0.63	-0.51	-4.37	-14.19	-	-
EV/Sales Ratio	-4.82	-4.82	-5.22	75.57	-	-	-
EV/EBITDA Ratio	0.88	0.88	0.77	-2.64	-8.71	2.01	6.27
EV/EBIT Ratio	0.85	0.85	0.74	-2.57	-8.41	1.92	5.67
EV/FCF Ratio	0.95	0.95	0.90	-2.83	-10.78	2.10	9.05
Debt / Equity Ratio	0.12	0.12	0.12	0.08	0.06	-0.22	-1.01
Debt / EBITDA Ratio	-0.13	-0.13	-0.13	-0.12	-0.14	-0.28	-1.12
Debt / FCF Ratio	-0.14	-0.14	-0.16	-0.12	-0.17	-0.29	-1.62
Quick Ratio	5.68	5.68	3.80	4.90	8.06	8.55	12.20
Current Ratio	5.90	5.90	4.03	5.25	8.26	8.70	12.33
Asset Turnover	0.13	0.13	0.08	0.02	0	0	-
Interest Coverage	-	-	-	-	-9.28	-	-50.22
Return on Equity (ROE)	-116.40%	-116.40%	-74.50%	-67.00%	-139.90%	132.90%	-
Return on Assets (ROA)	-75.40%	-75.40%	-54.60%	-54.30%	-52.70%	-41.10%	-
Return on Capital (ROIC)	-85.38%	-85.38%	-83.78%	-64.42%	-41.98%	106.89%	-11776.72%
Earnings Yield	-138.56%	-176.22%	-235.41%	-25.37%	-10.30%	-	-
FCF Yield	-124.87%	-158.81%	-196.90%	-23.04%	-7.24%	-	-
Buyback Yield / Dilution	-50.51%	-50.51%	-7.13%	-299.03%	-397.62%	81.93%	-
Total Shareholder Return	-50.51%	-50.51%	-7.13%	-299.03%	-397.62%	81.93%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).